Pharma Commercial Mock
← All views·CI feed·API docs
AASCO
Meeting Library
AACR Annual Meeting 2026 · San Diego, CA
5 shown of 9,799 total abstracts
  1. Abstract 63212026-04-04 · 15:15 CT · S100A
    Biomarker subgroup analysis of Opdivo in RCC (the CheckMate-417 study)
    S. Tolaney, S. Modi, S. Antonia, et al. · Princess Margaret Cancer Centre
    Clinical Science SymposiumGenitourinary Cancer—Kidney/Bladder📄🖼️
  2. Abstract 64112026-04-05 · 14:15 CT · E450
    Quality of life outcomes with Keytruda in patients with RCC
    C. Robert, J. Cortes, R. Herbst, et al. · MD Anderson Cancer Center
    Clinical Science SymposiumGenitourinary Cancer—Kidney/Bladder📄🖼️
  3. Abstract 66122026-04-02 · 14:45 CT · S406
    Biomarker subgroup analysis of Keytruda in RCC (the KEYNOTE-422 study)
    J. Cortes, S. Peters, T. Mok, et al. · Memorial Sloan Kettering Cancer Center
    Clinical Science SymposiumGenitourinary Cancer—Kidney/Bladder📄🖼️
  4. Abstract 68692026-04-03 · 21:15 CT · Hall B1
    Biomarker subgroup analysis of Opdivo in RCC (the CheckMate-770 study)
    M.C. Garassino, C. Saura · Karolinska Institute
    Clinical Science SymposiumGenitourinary Cancer—Kidney/Bladder📄🖼️
  5. Abstract 63702026-04-04 · 19:15 CT · Arie Crown Theater
    Quality of life outcomes with Opdivo in patients with RCC
    P. Schmid, R. Herbst, T. Mok · Johns Hopkins Kimmel Cancer Center
    Clinical Science SymposiumGenitourinary Cancer—Kidney/Bladder📄🖼️
© 2026 American Society of Clinical Oncology · Citations follow JCO supplement format:J Clin Oncol 44, 2026 (suppl 17; abstr XXXX). Demo mock.